Clinical Trials

B-Cure Laser’s clinical trials

In recent years, portable low-level laser therapy (LLLT) devices have made possible the management of acute and chronic pain in the comfort of your own home. At B-Cure Laser, our commitment is to delivering accurate, insightful information based on independent clinical trials. Through this content, we hope to help you understand how innovative pain relief treatments are made possible by our products.

Independent clinical trials demonstrate the positive impact of low-level laser technology in the treatment of acute and chronic pain, orthopaedic conditions, inflammation, sports injuries and wounds. Indeed, more than 2000 publications, including more than 100 double-blind studies, have supported the efficacy of low-level laser therapy.

How B-Cure Laser works

B-Cure Laser products emit a low-level laser beam within the range of 1-1000mW. It produces a coherent monochromatic beam of light with a defined wavelength, moving in one phase and direction.

As an LLLT-based device, B-Cure Laser stimulates photochemical effects rather than thermal effects on living tissues. It penetrates deeply through the affected tissue without generating heat or causing damage.

When laser light is absorbed by living tissue, biological reactions are triggered in the cells. Endogenous chemical substances are produced in the cells and transported by blood and lymphatic flow to other parts of the body. Therefore, the effects of cold laser light may extend beyond the local area, to deliver wider systemic effects.

The innovative electro-optic mechanism, delivers wide energy distribution to enable device use without need of protective eye goggles.

Clinical trials and results

Read on to discover how positive treatment was proven in six double-blind clinical trials, with a further five trials in progress.

Dental Implantations, Health Care Institution of Perm, Russia

The use of original LLLT techniques in prevention and treatment regimens before and after dental implantation significantly reduces the frequency and intensity of the pain symptom. Significance –  p<0.01.The results showed a decrease of temperature, drainage output, acute and *chronic pain relief and accelerated healing in laser group. Significance –  p<0.001 (pain).


Joint-Related * Chronic Pain(TMJ), Sapienza University in Rome, Italy

Clinical trial of 90 patients (30 B-Cure active Laser, 30 placebo, 30 pain relief medication) affected by Joint-Related Pain (TMJ).
The results:

The double blind clinical trial , involving 90 patients, has shown a significant acute and *chronic pain reduction in the active group vs the B-Cure Placebo Laser . Significance –  p<0.01

Pain reduction of the active group was not different than the drug group.

Published in: Cranio, April 2019


Joint-Related Pain (TMJ), University of Parma, Italy

A 50% decrease in acute and *chronic pain level within two weeks, compared to 8% within the control group.
Published in: The “Laser Therapy”, March 2015.


Post Laminectomy, Beneficência of Sao Paulo Hospital, Brazil

The results showed a decrease of temperature, drainage output, acute and *chronic pain relief and accelerated healing in laser group. Significance –  p<0.001 (pain).

The decrease of temperature is an objective measurement, which further supports the efficacy.

Published in: American Society for Laser Medicine and Surgery 2014. (Submission in process)


Shoulder Surgery, The Holy Family Hospital, Nazareth, Israel

Self-applied photobiomodulation following rotator cuff arthroscopic surgery PBM significantly accelerated subjective pain reduction at 3 and 6 months. This nonpharmacologic add-on therapeutic modality is easy to use and encourages active patient involvement. Its potential use in rehabilitation following other surgeries should be considered.